Medical Developments International Ltd - ESG Rating & Company Profile powered by AI
Full ESG assessment of Medical Developments International Ltd can be reached by signing up for free. The ESG assessment for Medical Developments International Ltd indicates its transparency towards the United Nations SDGs. Alternative companies in the rating peer group for Medical Developments International Ltd are displayed.
Medical Developments International Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Medical Developments International Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Medical Developments International Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Medical Developments International Ltd disclose current and historical energy intensity?
Does Medical Developments International Ltd report the average age of the workforce?
Does Medical Developments International Ltd reference operational or capital allocation in relation to climate change?
Does Medical Developments International Ltd disclose its ethnicity pay gap?
Does Medical Developments International Ltd disclose cybersecurity risks?
Does Medical Developments International Ltd offer flexible work?
Does Medical Developments International Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Medical Developments International Ltd disclose the number of employees in R&D functions?
Does Medical Developments International Ltd conduct supply chain audits?
Does Medical Developments International Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Medical Developments International Ltd conduct 360 degree staff reviews?
Does Medical Developments International Ltd disclose the individual responsible for D&I?
Does Medical Developments International Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Medical Developments International Ltd disclose current and / or historical scope 2 emissions?
Does Medical Developments International Ltd disclose water use targets?
Does Medical Developments International Ltd have careers partnerships with academic institutions?
Did Medical Developments International Ltd have a product recall in the last two years?
Does Medical Developments International Ltd disclose incidents of discrimination?
Does Medical Developments International Ltd allow for Work Councils/Collective Agreements to be formed?
Has Medical Developments International Ltd issued a profit warning in the past 24 months?
Does Medical Developments International Ltd disclose parental leave metrics?
Does Medical Developments International Ltd disclose climate scenario or pathway analysis?
Does Medical Developments International Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Medical Developments International Ltd disclose the pay ratio of women to men?
Does Medical Developments International Ltd support suppliers with sustainability related research and development?
Does Medical Developments International Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Medical Developments International Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Medical Developments International Ltd involved in embryonic stem cell research?
Does Medical Developments International Ltd disclose GHG and Air Emissions intensity?
Does Medical Developments International Ltd disclose its waste policy?
Does Medical Developments International Ltd report according to TCFD requirements?
Does Medical Developments International Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Medical Developments International Ltd disclose energy use targets?
Does Medical Developments International Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Medical Developments International Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Medical Developments International Ltd
These potential risks are based on the size, segment and geographies of the company.
Medical Developments International Limited manufactures and distributes pharmaceutical and veterinary products, and medical devices. The company operates through three segments: Pharmaceuticals, Medical Devices, and Veterinary Products. It offers asthma and COPD pressurized metered dose inhalers, as well as masks and peak flow meters for asthma management for use in home or in hospitals; Penthrox, a prescription only medicine for pain in trauma; and medical devices, such as CPR face shield key rings, CPR masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, OXI port carry and hand bags, resuscitation kits, oxygen therapy masks, and resuscitators. The company also provides veterinary anaesthetic machines, including animal asthma chambers, animal silicone face masks, animal air cushion face masks, resuscitators, MDI tourniquets, vaporisers, animal anaesthetic machines, breathing monitors, autoclavable and disposable CO2 absorbers, and accessories for anaesthetic machines. It operates in Australia, Europe, North America, the Middle East, Asia, and South Africa. The company was incorporated in 2003 and is headquartered in Scoresby, Australia.